Japanese pharmaceutical company Eisai has established a new digital health business targeting dementia.
WHY IT MATTERS
Eisai's newly formed wholly-owned subsidiary, Theoria Technologies Co., seeks to "accelerate the development of a dementia ecosystem." This ecosystem, according to a press release, will empower people with dementia to "live their fullest lives."
Commencing business in April 2024...
A research project led by researchers from the University of Melbourne will be receiving A$2 million ($1.3 million) in funding and support from Google.org.
The MATCH (Music Attuned Technology - Care via eHealth) project is one of the 15 projects selected for the $25 million AI for the Global Goals grant, which seeks to help organisations accelerate progress towards meeting the United Nation's...
1st Group sells MyHeath1st to HealthShare
ASX-listed 1st Group has sold its human health bookings business to digital health firm HealthShare for A$1.25 million ($830,000).
According to corporate disclosure, 1st Group is divesting its healthcare service search and appointment bookings platform MyHealth1st to plug cash outflows while focusing its capital investments on its other businesses,...
Medical AI company JLK from South Korea has received medical device approval from Food and Drug Administration Thailand for its AI brain image analysis solution.
Founded in 2014, the startup offers a range of image analysis tools under its Medihub platform, which supports the diagnosis of neurological and cancer diseases. It also operates other AI-powered platforms for telehealth, medical...
Fujifilm Corporation has developed AI technology that can predict whether patients with mild cognitive impairment will progress to Alzheimer's disease within two years.
According to a press statement, the AI Technology for AD Progression Prediction has been found to have high generalisability, predicting patients who would progress to AD with high accuracy, even for subjects from different...
SafelyYou, maker of AI-enabled technology for fall detection and prevention, scooped up $30 million in Series B funding months after the close of its $19.5 Series A round.
The round was led by Omega Healthcare Investors, with participation from SCAN Group.
Omega Healthcare Investors, a real estate investment trust that focuses on long term and senior care, also prepaid $10 million to install...
BrainCheck, the company behind a platform that helps assess cognitive impairment, has raised $10 million in Series B funding.
The round was led by Next Coast Ventures and S3 Ventures, with participation from Nueterra Capital, Tensility Ventures and True Wealth Ventures. BrainCheck also secured strategic investment from UPMC Enterprises and SelectQuote.
BrainCheck said the latest round of funding...
People across the South-West of England will be given access to digital health libraries, through a partnership between the Organisation for the Review of Care and Health Apps (ORCHA) and seven Integrated Care Systems (ICSs).
It follows the success of the Our Dorset programme, which allows health and care staff to recommend apps focused on mental health, dementia, diabetes and cancer support to...
Farrer Park Hospital, a private tertiary acute care provider in Singapore, has adopted an artificial intelligence-enabled MRI screening tool for dementia.
WHAT IT DOES
The AI-supported MRI volumetry screening tool is used to quantify brain tissue volume in patients suspected of having dementia. According to Dr Santhosh Raj, a consultant neuroradiologist and neurointerventionalist at FPH, the...
Houston, Texas-based BrainCheck has raised an $8 million Series A round for its enterprise software offering that digitizes traditional brain health tests. S3 Ventures and Tensility Venture Partners led the round, with additional participation from True Wealth Ventures and Nueterra Capital.
Founded in 2014, the company previously raised $3 million in 2016 and $1.5 million in 2017, but that $1.5...